David Lutje Hulsik
David Lutje Hulsik
Unknown affiliation
Verified email at lavatherapeutics.com
Title
Cited by
Cited by
Year
Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo
E Dolk, M Van Der Vaart, DL Hulsik, G Vriend, H de Haard, S Spinelli, ...
Applied and environmental microbiology 71 (1), 442-450, 2005
1492005
Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma …
G Bodon, R Chassefeyre, K Pernet-Gallay, N Martinelli, G Effantin, ...
Journal of Biological Chemistry 286 (46), 40276-40286, 2011
882011
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41
C Sabin, D Corti, V Buzon, MS Seaman, DL Hulsik, A Hinz, F Vanzetta, ...
PLoS pathogens 6 (11), e1001195, 2010
762010
Modular signature and data-capture system and point of transaction payment and reward system
L Fernando, A Rafii, N Williams, EA Bunn, A Valliani
US Patent App. 10/377,830, 2010
672010
Heavier-than-air flying machines are impossible
L Oliveira, T Hulsen, DL Hulsik, ACM Paiva, G Vriend
FEBS letters 564 (3), 269-273, 2004
652004
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C
N Strokappe, A Szynol, M Aasa-Chapman, A Gorlani, AF Quigley, ...
PloS one 7 (3), e33298, 2012
602012
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition
DL Hulsik, Y Liu, NM Strokappe, S Battella, M El Khattabi, LE McCoy, ...
PLoS Pathog 9 (3), e1003202, 2013
532013
Structural basis for ESCRT-III CHMP3 recruitment of AMSH
J Solomons, C Sabin, E Poudevigne, Y Usami, DL Hulsik, P Macheboeuf, ...
Structure 19 (8), 1149-1159, 2011
492011
Characterization of a trimeric MPER containing HIV-1 gp41 antigen
A Hinz, G Schoehn, H Quendler, DL Hulsik, G Stiegler, H Katinger, ...
Virology 390 (2), 221-227, 2009
392009
Crystal Structure of the Neutralizing Llama V HH D7 and Its Mode of HIV-1 gp120 Interaction
A Hinz, DL Hulsik, A Forsman, WWL Koh, H Belrhali, A Gorlani, ...
PloS one 5 (5), e10482, 2010
372010
Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling
A De Morrée, DL Hulsik, A Impagliazzo, HH van Haagen, P de Galan, ...
PLoS One 5 (8), e11940, 2010
262010
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1
RPJ Lai, M Hock, J Radzimanowski, P Tonks, DL Hulsik, G Effantin, ...
Journal of Biological Chemistry 289 (43), 29912-29926, 2014
252014
Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae
A Gorlani, D Lutje Hulsik, H Adams, G Vriend, P Hermans, T Verrips
Protein Engineering, Design & Selection 25 (1), 39-46, 2012
212012
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
E Voets, M Paradé, DL Hulsik, S Spijkers, W Janssen, J Rens, ...
Journal for immunotherapy of cancer 7 (1), 340, 2019
72019
Improving properties of llama heavy chain antibodies using in silico analysis
D Lutje Hulsik
University Utrecht, 2009
42009
Altered APRIL binding antibodies
H Van Eenennaam, A Van Elsas, DL Hulsik, JP Medema
US Patent 9,969,808, 2018
22018
Development of a first in class APRIL fully blocking antibody BION-1301 for the treatment of multiple myeloma
J Dulos, L Driessen, M Snippert, M Guadagnoli, A Bertens, DL Hulsik, ...
Cancer Res 77 (Suppl 13), 2645, 2017
12017
Development of an agonistic antibody against the human T-cell costimulatory receptor CD27 as a potential immunotherapeutic tool.
H van Eenennaam, E Veraar, W Mulder, E Bastiaanssen, L Driessen, ...
Cancer Research 73 (8 Supplement), 1246-1246, 2013
12013
Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates
CT Verrips, SM Van Der Maarel, P Verheesen, DL Hulsik, ...
US Patent App. 11/992,330, 2010
12010
Stability of llama heavy chain antibody fragments under extreme conditions
E Dolk
12004
The system can't perform the operation now. Try again later.
Articles 1–20